Solid Biosciences Inc.SLDBNASDAQ
LOADING
|||
Net Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-15.95%
↓ 119% below average
Average (36q)
-7.29%
Historical baseline
Range
High:28.87%
Low:-98.47%
Volatility
-1745.8%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -15.95% |
| Q2 2025 | -0.50% |
| Q1 2025 | 7.78% |
| Q4 2024 | -30.17% |
| Q3 2024 | -30.52% |
| Q2 2024 | -3.16% |
| Q1 2024 | -19.51% |
| Q4 2023 | 3.07% |
| Q3 2023 | 14.82% |
| Q2 2023 | 18.09% |
| Q1 2023 | -98.47% |
| Q4 2022 | 25.77% |
| Q3 2022 | 18.66% |
| Q2 2022 | 0.93% |
| Q1 2022 | -36.10% |
| Q4 2021 | -3.49% |
| Q3 2021 | 3.81% |
| Q2 2021 | -10.62% |
| Q1 2021 | 20.89% |
| Q4 2020 | -0.55% |
| Q3 2020 | -11.90% |
| Q2 2020 | 28.87% |
| Q1 2020 | 16.22% |
| Q4 2019 | -8.91% |
| Q3 2019 | -10.29% |
| Q2 2019 | 10.33% |
| Q1 2019 | -34.95% |
| Q4 2018 | -15.25% |
| Q3 2018 | -5.78% |
| Q2 2018 | -13.25% |
| Q1 2018 | -9.59% |
| Q4 2017 | -7.27% |
| Q3 2017 | -19.40% |
| Q2 2017 | 11.74% |
| Q1 2017 | -65.23% |
| Q4 2016 | 0.00% |
| Q1 2016 | 0.00% |